March 9, 2023
MDxHealth Announces Update of Outstanding Shares and Voting Rights
NEWS RELEASE – REGULATED INFORMATIONMARCH 8, 2023, 5:00 pm ET/ 23:00 CET IRVINE, CA, and HERSTAL, BELGIUM – March 8, 2023…
Pharmaceuticals, Biotechnology and Life Sciences
NEWS RELEASE – REGULATED INFORMATIONMARCH 8, 2023, 5:00 pm ET/ 23:00 CET IRVINE, CA, and HERSTAL, BELGIUM – March 8, 2023…
SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to…
TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB; OTCQX: MEDXF) today entered into a new senior…
Entered into a €40 million credit facility with the European Investment Bank and closed an approximatively $25 million follow-on equity…
Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million SOUTH ORANGE, NJ, March 08, 2023…
Webcast set for 7:30 a.m. ET on March 9SALT LAKE CITY, March 08, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq:…
Announced Expansion of Briquilimab (formerly known as JSP191) Development Strategy to Include Chronic Spontaneous UrticariaPresentation of Key Briquilimab Clinical Data,…
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 08, 2023 (GLOBE NEWSWIRE) — Vaxart, Inc.…
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D.,…
ROCKVILLE, Md., March 08, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…